Search the Newsreel

Recursion Pharmaceuticals (RXRX) Stock Dropped, So What Is Behind The Move?

Xenon Pharmaceuticals Independent Director Steven Gannon Sells 84% Of Holding

WYFI Stock Rallies On Earnings Beat, CEO Says NC-1 Has Entered ‘Active Customer Deployment’ With Initial Billing Underway

First Merchants Corporation Announces Cash Dividend

First Merchants Corporation announced a cash dividend of $0.37 per common share on August 14, 2026. The dividend is scheduled to be paid on September 18, 2026, to shareholders of record as of September 4, 2026. First Merchants Corporation is a financial holding company …

Super Hi International Holding Ltd. Financial Disclosures & Filings

This article provides an overview of Super Hi International Holding Ltd.'s financial disclosures and regulatory filings, allowing investors to access crucial information about the company's performance and strategy. It lists various earnings reports and annual reports from 2024 to 2026, highlighting key financial figures …

Theravance Biopharma Deal Faces Investor Probe

Halper Sadeh LLC is investigating the proposed acquisition of Theravance Biopharma (NASDAQ: TBPH) by Zymeworks Inc. for $17 per share in cash plus a contingent value right. The investigation aims to determine if Theravance shareholders are receiving a fair price and if the company's …

Dow, S&P 500, Nasdaq Futures Edge Higher On Cooling Inflation Signs, Strong Big Bank Earnings: IBM, APLD, SKYH, NBIS in Focus

Is Harte Hanks (NASDAQ:HHS) In A Good Position To Deliver On Growth Plans?

Prosperity Bancshares director Holmes sells $81,550 in stock By Investing.com

Ned S. Holmes, a director at Prosperity Bancshares Inc (NYSE:PB), recently sold common stock totaling $81,550 across various transactions on August 12, 2026. These sales occurred as the stock traded near its 52-week high, with shares sold directly, through a profit-sharing plan, and indirectly …

Hardwyn India net profit falls 22% to ₹28 million in Q1FY26

Principal Financial Group Inc. Buys 96,387 Shares of Nicolet Bankshares Inc. $NIC

VinFast falls 42% to Fair Value target as InvestingPro predicted By Investing.com

InvestingPro accurately predicted VinFast's (NASDAQ:VFS) 42% decline to its Fair Value target, demonstrating the importance of fundamental analysis. The electric vehicle maker, which was flagged as significantly overvalued in February 2024, saw its stock price align with the intrinsic value estimated by InvestingPro's models …

Clean Harbors co-CEO Gerstenberg sells $699,650 in stock

Clean Harbors co-CEO Eric W. Gerstenberg sold 2,500 shares of common stock for $699,650 on February 23, 2026. Following this sale, he directly holds 64,000 shares, and the stock has since appreciated over 15%. The company has also reported strong Q2 revenue and adjusted …

Prosperity Bancshares director Holmes sells $81,550 in stock

Prosperity Bancshares director Ned S. Holmes recently sold $81,550 worth of common stock through direct, profit-sharing plan, and trust transactions. The sales occurred on August 12, 2026, with shares trading near their 52-week high. These sales follow the bank's merger with Stellar Bancorp and …

Technical Reactions to AVBP Trends in Macro Strategies

This article provides a technical analysis of Arrivent Biopharma Inc. (NASDAQ: AVBP) trends, highlighting neutral near and mid-term readings but a potentially strong long-term positive bias. It details institutional trading strategies, including position, momentum breakout, and risk hedging, along with multi-timeframe signal analysis. The …

Top Xanadu Quantum Technologies Limited Class B Subordinate Voting Shares (XNDU) Competitors 2026

Walleye Capital LLC Acquires New Stake in Live Oak Bancshares, Inc. $LOB

Summit Global Investments Acquires Shares of 7,182 Vertex Pharmaceuticals Incorporated $VRTX

Summit Global Investments purchased 7,182 shares of Vertex Pharmaceuticals (NASDAQ:VRTX) in the second quarter, valued at approximately $3.57 million. Other hedge funds also adjusted their holdings, with institutional investors now owning 90.96% of the stock. Analysts currently have a "Moderate Buy" rating for VRTX …

Next Capital Management LLC Invests $1.51 Million in The Charles Schwab Corporation $SCHW

Next Capital Management LLC has acquired a new stake of 16,323 shares in The Charles Schwab Corporation (NYSE:SCHW), valued at approximately $1.51 million. This comes amidst other institutional investors modifying their holdings and a significant amount of insider selling, totaling over $41 million in …

7,506 Shares in Regeneron Pharmaceuticals, Inc. $REGN Acquired by Summit Global Investments

Summit Global Investments acquired 7,506 shares of Regeneron Pharmaceuticals (NASDAQ:REGN) valued at $4.68 million during the second quarter. Regeneron reported strong quarterly results, beating analyst estimates with $14.29 EPS and $4.29 billion in revenue, representing a 16.7% year-over-year increase. Despite a "Moderate Buy" consensus …

ENLT|Enlight Renewable Energy Ltd|Price:85.550|Chg%:-0.450

This article provides a comprehensive overview of Enlight Renewable Energy Ltd (ENLT) stock, including its current price, market capitalization, performance metrics, and key financial figures. It also details the company's profile, analyst ratings, and major shareholders. The stock is currently trading at 85.440 USD …

Rhythm Pharmaceuticals(RYTM.US) Officer Sells US$8.9 Million in Common Stock

An officer at Rhythm Pharmaceuticals (RYTM.US) recently sold a substantial amount of common stock, totaling US$8.9 million. This transaction indicates a significant insider sale for the company.

TBPH Stock Alert: Halper Sadeh LLC is Investigating Whether Theravance Biopharma, Inc. is Obtaining a Fair Price for its Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Theravance Biopharma, Inc. (NASDAQ: TBPH) to Zymeworks Inc. for $17.00 per share. The investigation focuses on whether Theravance's board failed to secure the best possible price, conducted a fair sales process, …

Walleye Capital LLC Buys Shares of 106,112 ANI Pharmaceuticals, Inc. $ANIP

Walleye Capital LLC has acquired a new position in ANI Pharmaceuticals, purchasing 106,112 shares valued at approximately $8.8 million, indicating growing institutional interest as hedge funds and other investors collectively own 76.05% of the company. ANI Pharmaceuticals recently surpassed quarterly earnings expectations, reporting adjusted …

Stack Financial Management Inc Makes New $41.30 Million Investment in L3Harris Technologies Inc $LHX

Stack Financial Management Inc has made a new investment of $41.30 million in L3Harris Technologies Inc (NYSE:LHX), acquiring 142,143 shares during the second quarter. This investment represents approximately 3.2% of Stack Financial Management Inc's portfolio, making L3Harris Technologies its seventh-largest holding. Other hedge funds …

Spyglass Pharma (NASDAQ:SGP) Upgraded to "Moderate Buy" at Raymond James Financial

Trifecta Capital Advisors LLC Purchases New Position in Vertex Pharmaceuticals Incorporated $VRTX

Trifecta Capital Advisors LLC has acquired a new position in Vertex Pharmaceuticals (NASDAQ:VRTX), purchasing 16,745 shares valued at approximately $8.318 million, making it their 27th largest holding. Other institutional investors like Capital Research Global Investors and State Street Corp also increased their stakes. This …

16,416 Shares in L3Harris Technologies Inc $LHX Acquired by Trifecta Capital Advisors LLC

Trifecta Capital Advisors LLC has acquired a new stake of 16,416 shares in L3Harris Technologies Inc (NYSE:LHX) during the second quarter, valued at approximately $4.77 million. This move is part of broader institutional investor activity, with several other firms also adjusting their positions in …

Oppenheimer Asset Management Inc. Makes New Investment in Vertex Pharmaceuticals Incorporated $VRTX

Oppenheimer Asset Management Inc. has acquired a new stake of 17,931 shares in Vertex Pharmaceuticals (NASDAQ:VRTX), valued at approximately $8.91 million during the second quarter. This new investment comes as other institutional investors have also adjusted their holdings in VRTX. Vertex Pharmaceuticals reported earnings …

Mill Capital Management LLC Invests $18.06 Million in L3Harris Technologies Inc $LHX

Mill Capital Management LLC has acquired a new position in L3Harris Technologies Inc (NYSE:LHX), purchasing 62,134 shares valued at approximately $18.06 million, making it their 24th largest holding. Other institutional investors have also adjusted their stakes in LHX. The company recently reported strong quarterly …

Jennison Associates LLC Has $28.60 Million Stock Holdings in Nicolet Bankshares Inc. $NIC

Walleye Capital LLC Acquires Shares of 179,992 Southern First Bancshares, Inc. $SFST

Walleye Capital LLC has acquired 179,992 shares of Southern First Bancshares, Inc. (NASDAQ:SFST) in the second quarter, valued at approximately $11.0 million, representing about 1.9% of the company. Institutional investors now collectively own 75% of SFST. Analysts maintain a positive outlook with a consensus …

86,249 Shares in Eton Pharmaceuticals, Inc. $ETON Acquired by Walleye Capital LLC

Walleye Capital LLC has acquired 86,249 shares of Eton Pharmaceuticals, Inc. (NASDAQ:ETON) during the second quarter, valued at approximately $3.12 million, representing a 0.31% stake in the company. This acquisition comes as Eton Pharmaceuticals reported strong quarterly results, exceeding revenue and EPS expectations, and …

Quantinno Capital Management LP Buys 24,878 Shares of Crinetics Pharmaceuticals, Inc. $CRNX

Quantinno Capital Management LP significantly increased its stake in Crinetics Pharmaceuticals, Inc. (CRNX) by 280.9% in Q1, acquiring an additional 24,878 shares to reach a total of 33,734 shares valued at $1.225 million. This comes as Crinetics Pharmaceuticals reported strong Q1 revenues of $25.12 …

California State Teachers Retirement System Grows Stock Holdings in Urogen Pharma $URGN

The California State Teachers Retirement System significantly increased its holdings in Urogen Pharma (NASDAQ:URGN) by 1,605.5% in the first quarter, now owning 38,750 shares valued at $697,000. Institutional investors collectively hold 91.29% of the company, which has an average analyst rating of "Moderate Buy" …

How Investors May Respond To ANI Pharmaceuticals (ANIP) Record Q2 Results And Reaffirmed 2026 Revenue Guidance